VCP Scanner
Stock Screener
Filter stocks with fundamental & technical criteria
Market Themes
Curated industry baskets & thematic leaders
Earnings Hub
Calendar, EPS surprise stats & earnings transcripts
Market News
Real-time market intelligence & AI overviews
Insider Buying
SEC Form 4 corporate insider purchases
LearnAll lessons
Candlestick Patterns44 candles, each on two real charts
Pattern GuidesThe playbooks' setups on real breakouts
GlossaryInvesting terms in plain English
MinerviniVCP SetupsTrend Template
O'NeilCup with HandleFlat BaseDouble BottomCANSLIM Leaders
QullamaggieHigh Tight FlagsFlag BreakoutsEpisodic PivotsMomentum Leaders
KellWedge PopEMA Crossback
LivermorePivotal Points
PatternsFalling Wedge & ChannelBase Breakouts
View All Playbooks...
BreakoutsScanner
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Index & ETFs
SPY vs QQQVTI vs VOOSPY vs IWM
Compare Any Stocks...
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
VisualizeInteractive multi-year financial charts
Watchlist
BreakoutsScanner
WatchlistPricing
Ctrl K
Pricing
QTEX
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Analyze deeply. Research with clarity.

Data updated daily

Product

  • Screener
  • Scanner
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • Pricing
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly market insights — free

© 2026 VCP Scanner
AboutPrivacyTermsRefund Policy
Not financial advice. Do your own research.
ScreenerBreakoutsScannerWatchlist
QTEXQTREX Quantum Ltd.
$1.09$45M
Overview & Tools
OverviewChart Terminal ↗Visualize
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice History
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Discovery & Screens
Live BreakoutsStock ScreenerOwnership
HomeStocksQTEXBalance Sheet

QTREX Quantum Ltd. (QTEX) Balance Sheet

8Y historyFree accessUpdated daily

The balance sheet reflects a deteriorating financial position, with total assets contracting to $4.5 million in 2025Q2 from $18.3 million in 2022Q3, while accumulated losses have reached $73.0 million.

Income StatementBalance SheetCash FlowRatios

QTEX Balance Sheet

Annual statement

QTEX Balance Sheet

QTREX Quantum Ltd. (QTEX) balance sheet — 8-year assets, liabilities & shareholders' equity history

AnnualQuarterly
MetricTTMDec'25Dec'24Dec'23Dec'22Dec'21Dec'20Dec'19Dec'18
Total Current Assets3.25M4.41M6.81M7.79M14.49M24.51M684K182K11K
Cash & Short-Term Investments2.13M3.26M5.78M7.36M13.9M23.75M496K96K8K
Cash Only2.13M3.26M5.11M5.04M6.78M23.75M496K96K8K
Short-Term Investments00668K2.32M7.12M0000
Accounts Receivable000432K0210K188K51K0
Days Sales Outstanding---------
Inventory711K735K444K0-279K336K034.95K-3K
Days Inventory Outstanding571.66478.21332.09--562.57-167.85-
Other Current Assets418K203K347K-176K-6.5M-213K0-34.95K0
Total Non-Current Assets1.2M930K1.26M1.52M1.52M1.36M303K192K0
Property, Plant & Equipment1.2M930K1.26M1.52M1.52M1.36M303K192K0
Fixed Asset Turnover0.31x0.31x---3.08x----
Goodwill000000000
Intangible Assets000000000
Long-Term Investments000000000
Other Non-Current Assets000000000
Total Assets4.45M5.34M8.07M9.31M16.01M25.87M987K374K11K
Asset Turnover0.06x0.05x---0.29x----
Asset Growth %-165.83%-33.82%-13.32%-41.86%-38.11%2521.07%163.9%3300%-
Total Current Liabilities2.83M2.82M3.37M2.98M1.66M4.31M951K4.99M40K
Accounts Payable170K107K154K198K152K93K3K74K0
Days Payables Outstanding165.0169.62115.18178153.68155.715.39355.39-
Short-Term Debt01.37M1.85M1.76M294K3.5M399K4.68M0
Deferred Revenue (Current)000000000
Other Current Liabilities2.36M-286K-277K-290K82K23K-74K00
Current Ratio1.15x1.56x2.02x2.61x8.72x5.68x0.72x0.04x0.28x
Quick Ratio0.90x1.30x1.89x2.61x8.89x5.60x0.72x0.03x0.35x
Cash Conversion Cycle406.65--------
Total Non-Current Liabilities348K194K378K588K873K1.2M1.74M28K0
Long-Term Debt000588K398K302K1.65M00
Capital Lease Obligations1.15M194K378K588K873K900K95K28K0
Deferred Tax Liabilities000000000
Other Non-Current Liabilities000-588K-398K0000
Total Liabilities3.17M3.02M3.75M3.57M3.19M5.52M2.69M5.01M40K
Total Debt640K1.56M2.51M878K1.46M1.48M2.32M4.84M0
Net Debt-1.49M-1.7M-2.6M-4.16M-5.33M-22.27M1.82M4.74M-8K
Debt / Equity0.50x0.67x0.58x0.15x0.11x0.07x---
Debt / EBITDA0.05x-219.18x-0.10x----
Net Debt / EBITDA-0.11x--227.66x--0.35x----
Interest Coverage--1512.67x--1127.60x-82.74x-2822.67x-1432.40x-507.33x-
Total Equity1.28M2.32M4.32M5.74M12.82M20.35M-1.7M-4.64M-29K
Equity Growth %-226.13%-46.25%-24.68%-55.25%-37%1294.48%63.28%-15903.45%-
Book Value per Share0.050.080.230.471.193.84-0.24-0.34-0.01
Total Shareholders' Equity1.28M2.32M4.32M5.74M13.63M20.35M-1.7M-4.64M-29K
Common Stock74.25M82.12M70.9M61.26M57.87M48.94M304K3K3K
Retained Earnings-72.97M-79.79M-66.57M-55.52M-44.23M-28.79M-11.84M-4.61M-33K
Treasury Stock000000000
Accumulated OCI0000-1.93M210K-635K-36K1K
Minority Interest000000000

Key Metrics

Growth RegimeMixed
ProfitabilityNegative
Balance SheetVulnerable
Cash FlowBurning
Top Statement Risk

Imminent capital dilution risk

Rapid Erosion of Asset Base

As reported in recent financial statements, IINN's total assets have contracted from $18.3 million in 2022Q3 to just $4.5 million by 2025Q2, signaling a significant depletion of the company's resource base as it continues to fund its pre-commercial development phase through existing cash reserves.

The consistent decline in total assets suggests that the company is consuming its capital at a rate that outpaces any potential value creation from its R&D activities. This trajectory implies that the firm is approaching a critical juncture where its ability to sustain operations without external financing will be severely compromised.

Liquidity Buffer Nearing Critical Threshold

Based on the latest quarterly data, IINN's cash position has dwindled to $2.1 million, which, when viewed alongside a current ratio of 1.15, indicates a narrowing margin of safety for a company with high fixed operating costs and no significant recurring revenue streams to offset its burn.

The sharp decline in the current ratio from 7.48 in 2022Q3 to 1.15 in 2025Q2 highlights a rapid deterioration in the company's short-term financial flexibility. Investors should monitor this trend closely, as the current liquidity profile may necessitate dilutive financing to maintain the ongoing regulatory and clinical development roadmap.

Equity Quality Diminished by Losses

According to the provided balance sheet figures, accumulated losses have reached $73.0 million, effectively eroding the company's equity base and leaving shareholders with a diminished claim on assets as the firm continues to prioritize R&D spending over the preservation of book value.

The persistent growth in negative retained earnings underscores the high-risk nature of the company's current business model, where capital is being systematically consumed to achieve clinical milestones. This trend suggests that the equity value is increasingly sensitive to the success of future regulatory submissions rather than current operational performance.

Hidden Risks in Asset Composition

While the company reports $1.2 million in net PPE, the lack of significant revenue generation suggests these assets may be primarily comprised of prototype equipment that could face substantial impairment risk if the ART system fails to secure necessary regulatory approvals or market adoption.

The reliance on specialized equipment for R&D purposes creates a potential valuation trap, as these assets lack the utility of commercial-scale manufacturing infrastructure. Analysts should consider that the book value of these assets may not reflect their true economic value in a liquidation or pivot scenario.

QTEX — Frequently Asked Questions

Quick answers to the most common questions about buying QTEX stock.

What are the total assets of QTREX Quantum Ltd. (QTEX)?

As of 2025, QTREX Quantum Ltd. (QTEX) had total assets of $5.3M including $4.4M in current assets.

How much debt does QTREX Quantum Ltd. (QTEX) have?

QTREX Quantum Ltd. (QTEX) carries total debt of $1.6M, offset by $3.3M in cash and short-term investments. Comparing total debt to cash helps evaluate the company's debt burden and net leverage.

What is the book value or shareholders' equity of QTREX Quantum Ltd.?

QTREX Quantum Ltd. (QTEX) has total shareholders' equity (book value) of $2.3M ($0.08 book value per share). Book value represents the net worth of the company belonging to common stock holders.

What is QTREX Quantum Ltd.'s current ratio and liquidity?

QTREX Quantum Ltd. (QTEX) reported a current ratio of 1.56x. A current ratio above 1.0x indicates that the company has more current assets than current liabilities, suggesting sufficient short-term liquidity.